OncoMed Pharmaceuticals and Bayer Schering Pharma Sign a Global Cancer Pact Targeting the Wnt Pathway
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 8 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1364 ISSN: 1756-7874
Section: Joint Venture
Fulltext:
Abstract
OncoMed Pharmaceuticals has formed its second global alliance with a major pharmaceutical company in three years, this time with Bayer Schering Pharma for the discovery, development and commercialisation of novel anticancer stem cell therapeutics targeting the Wnt signalling pathway...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS